The American Diabetes Association (ADA) will host its annual meeting in New Orleans from June 5-8. If you haven’t already, we encourage you to register and explore the latest advances in diabetes research, prevention, and care.

In its May 2025 Consensus Report, the ADA recommends liver fibrosis screening for patients with prediabetes or type 2 diabetes — particularly those with obesity — highlighting the growing importance of early detection.

Visit us at booth 2103 to learn more about OWLiver, the only non-invasive blood test designed to identify all harmful stages of MASLD.

The Liver Meeting 2026, organized by the American Association for the Study of Liver Diseases (AASLD), will be held in Denver, Colorado, from November 5-8. This premier event brings together clinicians, researchers, and industry professionals from around the globe to discuss the latest advancements in liver disease research, treatment, and transplantation. Attendees can expect scientific sessions, workshops, and networking opportunities. The meeting will also feature an exhibit hall with over 150 exhibitors showcasing cutting-edge products and services.

Registration for The Liver Meeting opens for active AASLD members on Wednesday, July 15.